Abstract:Objective: To investigate and analyze factors which effect autologous stem cell collection in patients with lymphoma and multiple myeloma (MM) during chemotherapy combined with G-CSF mobilization, for improving quality and effectiveness of autologous stem cell transplantation.Methods: A retrospective analysis was performed from April 1, 2006 to October 31, 2013 in our hospital and 128 lymphoma and MM patients whose autologous peripheral blood stem cells (PBSCs) were collected including 75 patients with malignant lymphoma,7 cases of Hodgkinu0027s lymphoma and 68 non-Hodgkinu0027s lymphoma (NHL) cases as well as 53 MM patients were enrolled. The stem cells of all patients were mobilized by chemotherapy combined with G-CSF and collected via a continuous flow cell separation instrument (COBE Spectra, Lakewood, CO). Mobilize failure was defined when the amount of CD34 + cells was less than 2.0 x 106 / kg, whereas ≥2.0 * 106 / kg was defined as successful mobilization. More than 5.0x 106 cells / kg or more was considrered as ideal mobilization. Univariate and multivariate regression analyses of factors for mobilization failure, successful mobilization and ideal mobilization acquisition were performed.Results: There were more CD34+ cells in MM patients than in lymphoma patients (P = 0.064). The collection rates of CD34 + cells in MM patients were ≥ 2.0 x106 / kg in 64.8% (83 cases) and ≥ 5.0 x 106 / kg in 35.2% (45 cases). MM patients with a success collection ratio was 73.6 % (39/53) and the ideal collection rate was 43.4% (23/53), which was higher than in the NHL group with a success rate and ideal rate of 58.7% (44/75) and 30.7% (23/75). A total of 35.2 % (45 cases, including 31MM cases and 14 lymphoma cases) a mobilization was not successful.Conclusion: In different chemotherapy regimens in patients with lymphoma, remission, ever use MTX and/or Ara-c treatment and collecting the outer peripheral hematocrit could significantly affect the success rate of stem cell collection; In MM patients, who received lenalidomide treatment and multiple courses of treatment, still not got CR, which these reasons were the factors of non- successful mobilization.Although Plerixafor and peripheral blood CD34-positive cell counts could help to improve the success collection rate and predict collection rate, but there is still a need for further improvement of the current mobilization protocols, recognizing the ideal stem cell collection dynamics, efficiency and cost in order to select the appropriate mobilization protocols.Disclosures No relevant conflicts of interest to declare.

Effects of peripheral blood CD34 + cells count on the collection timing and results of peripheral blood stem cells

A Retrospective Study of Autologous Stem Cell Mobilization by G-CSF in Combination with Chemotherapy in Patients with Multiple Myeloma and Lymphoma.

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

Clinical Analysis on the Mobilization and Collection of Peripheral Hematopoietic Stem Cells in 198 Healthy Donors

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

Significance of peripheral CD_(34)~+ cell count on the harvest of mobilized peripheral hematopoietic stem cells

Clinical Analysis of the Factors Influencing the Mobilization and Collection of Peripheral Hematopoietic Stem Cells in Acute Leukemia Patients

[Clinical Analysis of Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization Regimen in Patients with Malignant Hematological Diseases].

Dynamics of monocyte count: a good predictor for timing of peripheral blood stem cell collection.

Chemotherapy Combined With Granulocyte Colony Stimulating Factor (G-Csf) For Mobilization Of Cd34(+) Cells In Lymphoma And Multiple Myeloma Patients

Hematopoietic Progenitor Cell Counting for Prediction of the Yield of Peripheral Blood Stem Cell in Mobilization and Harvest

Research Progress on Clinical Significance of Peripheral Blood CD34 + Cells Count in Autologous Stem Cell Mobilization and Collection

Effect observation of different collection procedures of blood cell separator on collection of autologous peripheral blood hematopoietic stem cells in children

Combined peripheral blood monocyte count and white blood cell count as a guide for successful one-day autologous peripheral blood stem cell collection

Investigation of the effect of collecting peripheral blood stem cell/progenitor cell with Amicus blood cell separator

Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study

Evaluate the Side Effect Associated with Mobilization and Harvesting of Peripheral Blood Hematopoietic Stem Cells (PBSC)

Peripheral Blood Stem Cell Collection in Pediatric Donors with Malignancies and Its Significance on Hematopoietic Recovery of Recipients

Predictive Modeling of Hematopoietic Stem Cell Mobilization and Collection Based on Peripheral Blood Marker

Mobilization and Collection of Peripheral Blood Stem Cells with COAEP Plus G-CSF Regimen in Autologous Peripheral Blood Stem Cell Transplantation

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors